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Kidney injury molecule-1 (KIM-1) is a specific histological
biomarker for diagnosing early tubular injury on renal
biopsies. In this study, KIM-1 expression was quantitated in
renal transplant biopsies by immunohistochemistry and
correlated with renal function. None of the 25 protocol
biopsies showed detectable tubular injury on histologic
examination, yet 28% had focal positive KIM-1 expression.
Proximal tubule KIM-1 expression was present in all biopsies
from patients with histological changes showing acute
tubular damage and deterioration of kidney function. In this
group, higher KIM-1 staining predicted a better outcome
with improved blood urea nitrogen (BUN), serum creatinine,
and estimated glomerular filtration rate (eGFR) over an
ensuing 18 months. KIM-1 was expressed focally in affected
tubules in 92% of kidney biopsies from patients with acute
cellular rejection. By contrast, there was little positive
staining for Ki-67, a cell proliferation marker, in any of the
groups. KIM-1 expression significantly correlated with serum
creatinine and BUN, and inversely with the eGFR on the
biopsy day. Our study shows that KIM-1 staining sensitively
and specifically identified proximal tubular injury and
correlated with the degree of renal dysfunction. KIM-1
expression is more sensitive than histology for detecting
early tubular injury, and its level of expression in transplant
biopsies may indicate the potential for recovery of kidney
function.
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Better tools are needed to identify tubular epithelial cell
injury in the kidney. Even when biopsy tissue is available, it is
difficult to define early signs of injury. Active tubular injury,
which is a cellular pathological description, can cause acute
kidney injury, a clinical syndrome, which is increasing in
prevalence and is associated with significantly increased
mortality and hospitalization cost.1,2 In renal allografts,
tubular injury associated with ischemia, nephrotoxicity
secondary to immunosuppressive medication, and/or acute
cellular rejection can lead to chronic allograft nephropathy
and eventual graft failure.3 Pre-renal and post-renal factors
contributing to renal failure are not always easily distin-
guished from intrarenal injury in allograft recipients.
Changes in kidney epithelial cell morphology in allograft
biopsies can vary from no or minimal histologic changes of
proximal tubules to diminished brush borders, apoptosis
and/or necrosis, dilated tubules, and sloughed epithelial cells
in the tubular lumina.4,5 A pathologic diagnosis of acute
tubular injury is often quite subjective. A sensitive tissue
biomarker of tubular injury, which can be used to identify or
confirm the presence of epithelial cell injury when patholo-
gical changes are minimal would be very helpful in the
evaluation of biopsy specimens.
Kidney injury molecule-1 (KIM-1) is a type I transmem-
branous protein whose expression is undetectable in normal
renal tissue and is markedly upregulated with injury of
proximal tubule epithelial cells in rats4–8 and has been reported
to be upregulated in a limited number of native human
biopsies where acute tubular injury was diagnosed histo-
logically.9 In this study, we used immunohistochemical tech-
niques to characterize the expression of KIM-1 in renal trans-
plant biopsies and to compare this staining with morphological
findings of tubular injury and acute cellular rejection. We also
determined whether there was a significant correlation between
renal functional indices and KIM-1 staining intensity. We
found that KIM-1 expression is more sensitive than histology
for detecting early tubular injury in human allografts.
RESULTS
General evaluation of KIM-1 staining intensity
There was no immunohistochemical expression of KIM-1 in
a large number of benign human tissues including normal
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human fetal and adult kidneys and lymphoid tissue,
including thymus, bone marrow, and tonsils (Table 1). The
positive control kidney tissue came from the viable portion of
infarcted transplant kidney, where there was KIM-1 expres-
sion along the luminal plasmalemmal surface of the proximal
tubular epithelium in a geographic pattern. Positive staining
extended into some disrupted cellular junctional areas
(Figure 1a and c). Distal nephron segments positive for
cytokeratin 7 and kidney-specific cadherin were negative for
KIM-1 staining, indicating specificity of KIM-1 for proximal
tubules (Figure 1a and c). In the medulla, KIM-1-positive
epithelial casts were present in the lumen of the distal
nephron (Figure 1b and d).
Expression of KIM-1 in allograft biopsies
Kidney tissue was classified into three groups. Kidney
recipients in the three groups were similar in age (Table 2).
The duration of time from transplantation to the day of
biopsy was significantly longer in group 3 (acute cellular
rejection, ACR group) when compared with groups 1
(protocol biopsy group) and 2 (acute tubular injury, ATI
group) (Table 2). In all cases in groups 1 and 2, minimal
interstitial fibrosis was noted. In group 3, some interstitial
spaces were occupied with inflammatory cells. No glomer-
ulopathy was evident on light microscopy in any of the
groups. The frequency of KIM-1-positive staining in each
group is listed in Table 3. Immunohistochemical expression
of KIM-1 in group 1 was absent in all nephron segments and
vessels in 72% of cases (Figure 2a). In 7 of 25 cases, however,
there was low-grade staining of proximal tubules for KIM-1
in these protocol biopsies. There was no difference in
morphology between KIM-1-positive and -negative cases.
This indicates that KIM-1 expression is more sensitive than
normal histology for detection of low-grade proximal tubule
injury. In group 2, when morphologic tubular injury was
obvious on hematoxylin–eosin stained sections (with dimin-
ished brush borders on Periodic acid-Schiff sections), KIM-1
expression was seen in 100% of cases. Kidney injury
molecule-1-positive staining was characteristically localized
along the plasmalemmal surface of proximal luminal
epithelium and extended into the lateral cellular membranes
when epithelial junctions appeared disrupted (Figure 2b).
The basal aspect of the epithelium was negative for KIM-1
staining even when there was marked tubular injury
morphologically. It was noted that even when inflammatory
infiltration and tubulitis were prominent in the group 3
biopsies, KIM-1 expression was localized to apical regions of
a subset of proximal tubules (Figure 2c; Table 4). Inflam-
matory cells, including lymphocytes, monocytes, and plasma
cells, were entirely negative for KIM-1 staining in all biopsies.
Overall, group 2 had the highest intensity score of KIM-1
staining, followed by groups 3 and 1 in that order (Table 4).
Proliferation of proximal tubules cells was evaluated by
positive staining of nuclei for Ki-67. Ki-67 expression was
minimal when compared to KIM-1 expression in groups 2
and 3, and there was nearly no positive staining for Ki-67
identified in group 1 (Table 4).
KIM-1 expression was significantly correlated with renal
dysfunction
Serum creatinine and blood urea nitrogen (BUN) were all
significantly higher, and estimated glomerular filtration rate
(eGFR) significantly lower, in groups 2 and 3 compared with
group 1 (Table 4). When groups of cases were analyzed
together to correlate the KIM-1 staining score with measures
of renal function, KIM-1 immunoreactivity was significantly
Table 1 | Negative immunohistochemical expression of KIM-1
in benign human tissues
Different types of human tissue
Pediatric and adult thymus (n=6, excision)
Adult livers (n=6, wedge biopsy)
Sinusitis (n=40, tissue microarray)
Tonsils (n=40, tissue microarray)
Uninjured fetal kidneys (n=3, 12–28 weeks of gestational age, without
autolysis)
Benign bone marrow (n=10, biopsy)
Benign human tissue microarray (n=3 each) including adrenal gland,
cerebrum, cerebellum, pituitary gland, breast, uterine cervix, colon,
esophagus, heart, kidney, testis, salivary gland, liver, lung, skin, striated
muscle, pancreas, placenta, prostate, small intestine, spleen, bone
marrow, stomach, thymus, thyroid, parathyroid, tonsil, endometrium,
nerve, ovary, fallopian tube, and ureter
KIM-1, kidney injury molecule-1.
a b
c d
Figure 1 | Expression of KIM-1 in a positive control transplant
tissue (a nephrectomy specimen following embolism in a renal
transplant). Proximal tubules with prominent acute tubular injury
showed dilation and flat epithelium. There was strong positive
brown (peroxidase) KIM-1 staining (a and c). Cytokeratin-7 (a) or
kidney-specific cadherin (c) expression in non-proximal tubules (N) is
depicted in red (alkaline phosphatase). Glomerulus (G) is negative for
expression of KIM-1, cytokeratin-7, or kidney-specific cadherin. In the
medulla, the lumina of non-proximal tubules (N), indicated by either
cytokeratin-7 (b) or kidney-specific cadherin (d), contained sloughed
KIM-1-positive casts (brown color in b and d). Small vessels are
negative for KIM-1 (both b and d), cytokeratin-7 (b), or kidney-specific
cadherin stains (d) (original magnification  600 in a–d).
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positively correlated with BUN and creatinine across the
entire three groups as well as in each study subgroup
(Figure 3). In addition, KIM-1 positivity was also inversely
and significantly correlated with the eGFR of the combined
three groups (r¼ 0.587, Po0.0001).
KIM-1 staining is correlated with change in renal function
in patients with acute tubular injury but not in patients
with undetectable pathological evidence of tubular injury
over 18 months of follow-up
When the renal function of patients (n¼ 18) with protocol
biopsies negative for KIM-1 staining was compared to seven
patients with protocol biopsies positive for KIM-1 staining
(all from group 1) on the day of biopsy and 6, 12, and 18
months after biopsy, there was no significant difference in
BUN, serum creatinine, or eGFR at any of the time points
(Table 5). Since the tubular injury in these protocol biopsies
was minimal, we then examined the change in renal function
over time in those patients with acute tubular injury (group
2) and evaluated whether the extent of KIM-1 staining at the
time of biopsy was correlated with changes in renal function
over 18 months subsequent to biopsy. We found that the
patients with greater levels of KIM-1 staining (2þ or 3þ )
had better recovery of function over time (Table 6; Figure 4)
as reflected by reduction in BUN, serum creatinine, and
increase in eGFR.
DISCUSSION
Evaluation of KIM-1 staining may serve to optimize the
diagnosis of tubular injury in allograft biopsies. Our data
indicate that KIM-1 protein expression in proximal tubules is
significantly correlated with renal dysfunction. All patients in
whom KIM-1 positivity was at a level of 1þ or greater had
diminished renal function (serum creatinine levels 41.4 mg
per 100 ml and serum BUN levels 420 mg per 100 ml). The
Table 2 | Profiles of patients with renal transplants in three groups
Groups N Pathologic description Age (years) Gender Duration from Tx to Bx day (weeks)
1 25 Protocol biopsies 44.8±2.9 12 female/13 male 20.3±4.1
2 25 Active tubular injury 49.0±2.9 9 female/14 male 16.0±8.1
3 12 Acute cellular rejection 44.3±4.5 6 female/6 male 78.8±19.5*#
Tx, transplantation; Bx, biopsy.
*Po0.05 vs group 1; #Po0.05 vs group 2.
Table 3 | Distribution of KIM-1 staining intensity in each of the groups
KIM-1 staining intensity (percentage of biopsies, %)
Groups Description 0 0.5 (±) 1+ 2+ 3+
1 Protocol biopsies 18/25 (72) 6/25 (24) 1/25 (4) 0/25 (0) 0/25 (0)
2 Active tubular injury 0/25 (0) 0/25 (0) 15/25 (60) 8/25 (32) 2/25 (8)
3 Acute cellular rejection 1/12 (8) 4/12 (33) 5/12 (42) 2/12 (17) 0/12 (0)
KIM-1, kidney injury molecule-1.
Table 4 | Renal functional indices, kidney injury molecule-1 (KIM-1), and Ki-67 staining scores
Groups Description BUN (mg per 100 ml) Cr (mg per 100 ml) BUN/Cr ratio eGFR (ml min1) KIM-1 scores Ki-67 scores
1 Protocol biopsies 22.8±1.8 1.43±0.09 16.22±0.89 48.9±2.2 0.16±0.06 0.02±0.02
2 Active tubular injury 46.2±4.4* 3.43±0.46* 15.42±1.09 22.8±3.1* 1.48±0.13* 0.13±0.09*
3 Acute cellular rejection 43.9±4.8* 3.22±0.50* 15.11±1.41 26.8±4.1* 1.00±0.18*# 0.17±0.11
BUN, blood urea nitrogen; Cr, serum creatinine; eGFR, estimated glomerular filtration rate.
*Po0.05 vs protocol biopsies; #Po0.05 vs active tubular injury group. Data are expressed as mean±s.e.
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Figure 2 | KIM-1 expression in transplant biopsies. KIM-1
expression in protocol biopsy (a), acute tubular injury (b), and acute
cellular rejection (c). (a) No KIM-1 staining was present in any
compartment of this protocol renal transplant biopsy. (b) When
active tubular injury was present, upregulated KIM-1 expression
(3þ ) was seen along the luminal surface of proximal tubules. (c) With
acute cellular rejection, a proximal tubule was positive for KIM-1
staining (1þ ), whereas inflammatory cells were not reactive with
the AKG7 antibody (original magnification  400 in a–c).
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fact that 28% of protocol biopsies had either 0.5± (24%) or
1þ (4%) KIM-1 staining suggests that KIM-1 staining is
very sensitive as a marker for early kidney tubular injury. It
could be argued that this might be a false-positive finding.
Arguing against this is the exhaustive animal data carried
out by a number of laboratories with agreement that Kim-1
is not expressed in normal kidney. Furthermore, we have
found very good correlation between Kim-1 mRNA tissue
expression and urinary Kim-1 in animals,7 and we consis-
tently find that urinary KIM-1 is absent in humans without
kidney disease.
In animal studies, we know that many factors leading to
tubular epithelial cell injury result in Kim-1 protein
expression. Both gene and protein products of Kim-1 are
upregulated by 3 h after renal ischemia–reperfusion injury in
animal models.7 Cisplatin, folic acid, S-(1,1,2,2-tetrafluoro-
ethyl)-l-cysteine, 5 cyclosporine,10,11 and other nephro-
toxicants12 also result in Kim-1 upregulation. In addition,
Kim-1 protein is expressed in the kidneys of a transgenic
rat that develops tubular-interstitial disease secondary to
enhanced activity of the renin–angiotensin system,6 and is
also expressed in animal models of protein overload nephro-
pathy8 and obstruction.13 In microarray studies of kidneys
from hypotensive brain dead rats, Kim-1 was found to be
highly upregulated 6 h following brain death.14
Our data in animal models indicate that Kim-1 expres-
sion was localized only to proximal tubules following
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Figure 3 | KIM-1 staining was significantly correlated with serum
creatinine (upper panel) and BUN (lower panel) across all groups.
Table 5 | Renal functional indices in protocol biopsies with
negative or positive KIM-1 stains
Protocol biopsies
KIM-1-negative
cases (n=18)
KIM-1-positive
cases (n=7)
KIM staining scores
(arbitrary units)
0.00±0.00 0.57±0.07*
BUN (mg per 100 ml)
Biopsy day 22.39±1.59 24.00±5.21
6-month follow-up 21.72±1.6 20.71±5.17
1-year follow-up 22.39±1.60 22.17±1.64
1 and ½-year follow-up 22.14±2.48 19.43±2.26
Cr (mg per 100 ml)
Biopsy day 1.41±0.08 1.51±0.27
6-month follow-up 1.44±0.11 1.47±0.24
1-year follow-up 1.49±0.11 1.57±0.21
1 and ½-year follow-up 1.44±0.10 1.46±0.22
eGFR (ml min1)
Biopsy day 49.68±2.37 48.76±5.80
6-month follow-up 48.76±2.68 49.13±5.13
1-year follow-up 47.26±2.62 46.76±4.90
1 and ½-year follow-up 49.14±2.83 49.49±5.14
BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate;
KIM-1, kidney injury molecule-1.
*Po0.05.
Table 6 | Renal functional indices over 18 months in patients
with ATI with either low (1+) or high (2 to 3+) level of KIM-1
kidney tissue expression by immunohistochemistry
Protocol biopsies
KIM-1 staining
scores: 1+ cases
(n=15)
KIM-1 staining
scores: 2 to 3+ cases
(n=10)
KIM staining scores
(arbitrary units)
1.00±0.00 2.20±0.13*
BUN (mg per 100 ml)
Biopsy day 40.93±4.53 54.10±8.47
6 months after biopsy 35.71±5.97 29.90±4.11#
12 months after biopsy 28.69±2.80 26.56±2.05#
18 months after biopsy 30.79±2.77 26.00±2.39#
Cr (mg per 100 ml)
Biopsy day 3.02±0.52 4.05±0.83
6 months after biopsy 2.90±0.66 1.98±0.30#
12 months after biopsy 2.85±0.65 1.62±0.11#
18 months after biopsy 2.68±0.53 1.62±0.13#
eGFR (ml min1)
Biopsy day 30.76±4.54 25.16±5.17
6 months after biopsy 32.24±4.18 43.04±4.63#
12 months biopsy 31.21±3.92 48.39±3.05*#
18 months after biopsy 32.16±4.04 49.37±3.82*#
ANOVA, analysis of variance; ATI, active tubular injury; BUN, blood urea nitrogen;
Cr, serum creatinine; eGFR, estimated glomerular filtration rate; KIM-1, kidney injury
molecule-1.
*Po0.05 vs KIM-1 1+ positive group (by unpaired Student t-test).
#Po0.05 vs biopsy day value (by ANOVA).
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ischemia–reperfusion and nephrotoxicant injury in rat
kidneys.4,5 The current study confirms that KIM-1 protein
expression is localized to the injured human proximal tubular
epithelia (Figure 1a and c). Since the AKG7 antibody is reac-
tive with the metalloproteinase-released ectodomain,15 the
KIM-1-positive staining in the lumen of distal nephron
tubules represents reaction of the antibody with KIM-1 ecto-
domain released from the proximal tubules, which then
moved within the tubule to more distant segments of
nephrons (Figure 1b and d). We noted KIM-1-positive stain-
ing in some atrophic tubules with surrounding fibrosis and
inflammation. Although the function of KIM-1 is unclear,
this finding supports our previously published hypothesis
that KIM-1 might be involved in the development of inter-
stitial fibrosis following injury.13 If so, then KIM-1 expression
in the allograft may have important implications for chronic
allograft nephropathy. The data also indicate that there may
be a significant difference on outcome with respect to the
temporal character of KIM-1 expression. Given an equivalent
level of diminished renal function in patients with allografts,
as measured by eGFR, a high level of KIM-1 expression was
found to be a good prognostic sign. This suggests that the
reason for the reduction in renal function was more acute
and involved tubules that were able to generate a robust
KIM-1 response. In a patient with an allograft, a lower level
of KIM-1 expression might be reflective of more chronicity
and hence potentially less reversibility.
Pre-renal and post-renal factors contributing to renal
dysfunction are not always easily distinguished from early
tubular injury in renal transplant recipients. The absence of
KIM-1 expression in human allograft biopsies would suggest
that the cause of clinical renal dysfunction in these patients
was related to pre-renal causes or cellular rejection with
inflammation in the absence of significant epithelial cell
injury. In 28% of protocol biopsies with no obvious patho-
logical abnormalities, however, there was KIM-1-positive
staining, indicating that there was injury at a time when the
pathological evaluation was not sensitive enough to identify
this. This could dictate therapeutic changes.
These observations indicate that KIM-1 staining is a very
sensitive and specific indicator for tubular injury in human
allografts as we have found in animals.16 Furthermore, KIM-1
immunoreactivity was much more sensitive than Ki-67
positivity for detecting tubular injury (Table 4). Concurrent
expression of KIM-1 and Ki-67 in groups 2 and 3 implies that
tubular injury, epithelial cell dedifferentiation, and tubular
regeneration processes can occur contemporaneously.
Kidney injury molecule-1-positive staining scores were
significantly higher in group 2 when compared with group 3,
whereas serum creatinine and BUN levels were similar in
groups 2 and 3, reflecting additive detrimental functional
effects of the lymphocytic infiltration in group 3. Within
group 3, the KIM-1 staining score was significantly correlated
with renal dysfunction, indicating that proximal tubular
injury may contribute in an important way to renal func-
tional deficit even when inflammatory cells dominate the
pathology.
Kidney injury molecule-1 is identical to T-cell immuno-
globulin and mucin-domain-containing molecule-1, which
has been reported to be present in T lymphocytes (parti-
cularly Th2 cells) and to potentially be involved in auto-
immune disorders.17–19 The antibody, AKG7, however, has a
high specificity in recognizing upregulated KIM-1 antigen
in injured renal tubules and does not react with infiltrating
T lymphocytes, other types of inflammatory cells, or other
examined organs in humans (Table 1) using the methods
we have employed. Native inflammatory cells (thymus, bone
marrow, and tonsils) and inflammatory cells that have
migrated into tissue (in 40 cases of sinus tissue with rhinitis
including lymphocytes, plasma cells, monocytes, neutrophils,
and eosinophils) were negative by AKG7 staining (Table 1).
In conclusion, tissue KIM-1 staining is a very useful
biomarker to diagnose kidney epithelial cell injury in renal
allografts. Positive staining in proximal tubules correlates
very well with renal dysfunction. When a renal transplant
recipient has renal dysfunction without acute cellular rejec-
tion present in the renal biopsy, negative staining of KIM-1
suggests that renal dysfunction is not associated with tubular
injury and may be attributed to pre-renal factors. The level to
which KIM-1 staining is seen in the tubules in kidneys with
acute cellular rejection reveals the extent of damage to the
tubules and correlates with functional deficits. On the basis of
this study, we propose to use KIM-1-positive staining as a
standard to limit subjective error and confirm tubular injury
in the evaluation of renal transplant biopsies.
MATERIALS AND METHODS
Renal transplant biopsies
Cases were selected at random from renal transplant biopsies performed
from 2003 to 2005 at Geisinger Medical Center (Danville, PA,
USA). With only a few exceptions (prior to May 2003), renal allo-
graft recipients received intraoperative Campath-1H (Alemtuzumab;
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Figure 4 | For equivalent levels of renal dysfunction at the time
of biopsy, a higher KIM-1 staining score, reflecting more acute
injury, is predictive of improvement in eGFR over the ensuing 6,
12, and 18 months. *Po0.05 vs KIM-1 1þ positive group;
#Po0.05 vs biopsy day value.
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Genzyme Corporation, Cambridge, MA, USA) induction and post-
operative immunosuppression. The pretreatment regimen included
1 g of methylprednisolone i.v., 650 mg of acetaminophen p.o., 50 mg
of diphenhydramine i.v., and 30 mg of Campath-1H i.v. over 2 h
(given before unclamping of the transplanted kidney’s vessels).
Postoperative immunosuppression included FK 506 (target level
of 10 ng ml1 from day 1) or mycophenolate mofetil, 1 g b.i.d. from
day 1 (mycophenolate mofetil was preferentially given to expanded
criteria donors, non-heart-beating donors, and to donors of age
o10 years). In addition, all patients received prednisone 20 mg once
a day from day 1, with a subsequent wean to 0 mg in 8 weeks
(reduced 2.5 mg every week). Each patient also received Valgancy-
lovir 450–900 mg a day for cytomegalovirus prophylaxis from the
first week post transplant (duration and dosing of Valgancyclovir
was dependent on renal function and pretransplant donor and
recipient cytomegalovirus status). Testing for cytomegalovirus
antigenemia was carried out once a week for the first 3 months,
once every 2 weeks from months 3 to 9, and once a month after
month 9. Patients were followed with weekly laboratory tests. Renal
biopsies were performed as clinically indicated to rule out acute
cellular rejection and/or by protocol at 2 weeks, 3 months, and
1 year. Renal functional indices, including serum creatinine, BUN,
and eGFR, were obtained from the Geisinger Epicare system. In
the Geisinger clinical laboratory, the eGFR was calculated using a
standard formula from the National Kidney Foundation: (eGFR¼
186 (SCr)1.15 (Age)0.20 (0.742 if female) (1.21 if African
American).
Grouping renal cases
Three groups were identified via a computer search based on
ICD9 codes. The control group included protocol renal transplant
biopsies done less than 1 year following renal transplantation (group
1). All protocol biopsies were interpreted as having no significant
pathology by one of the authors (PLZ), a renal pathologist. Group 2
included cases with obvious pathological findings of proximal
tubular injury including dilation of tubules, diminished brush
borders, and flat and detached epithelia, whereas no acute cellular
rejection was present. This group was designated the active tubular
injury group. Group 3 was composed of cases where the pathology
revealed mild acute cellular rejection (ACR) (Banff criteria Ia and Ib).20
Histology and immunohistochemical staining for KIM-1 and
proliferative nuclear antigen Ki-67
The renal biopsy tissue was fixed in formalin and paraffin
embedded. The tissue block was cut into 3-mm sections and under-
went routine staining for hematoxylin–eosin staining (three
sections), Periodic acid-Schiff staining (three sections), and Masson
Trichrome staining (one section). For each block, one 3-mm section
was dewaxed in xylene and rehydrated with graded ethanols to
water. AKG7, a mouse monoclonal antibody against the ectodomain
of human KIM-1,15 was used in the study. The stock concentration
of AKG7 was 1 mg ml1. The slides were treated with a 20 min
heat-induced antigen retrieval protocol (Target Retrieval Solution,
DakoCytomation, Carpinteria, CA, USA). Primary AKG7 antibody
(diluted 1:8 with antibody diluent; DakoCytomation) was applied
for 1 h. The secondary antibody (peroxidase-labeled goat anti-
mouse; Envþ kit; DakoCytomation) was applied for 30 min. DAB
(3,30-diaminobenzidine; Envþ kit; DakoCytomation) was applied
for 10 min. KIM-1 positivity was reflected as brown staining of
the proximal tubules. KIM-1 staining was also performed on a large
number of benign human tissues from Geisinger Medical Center,
and on an FDA true 33 normal tissue screen tissue array (Cybrdi
Inc., Gaithersburg, MD, USA).
To identify parts of the nephron distal to the proximal tubule, in
some cases, after staining for KIM-1, the tissue sections were treated
with Denaturing Solution (Biocare Medical, Concord, CA, USA) for
5 min, rinsed with Tris-buffered saline with Tween 20 buffer, and
costained with cytokeratin-7 primary antibody (diluted 1:100;
Biocare Medical) for 1 h. The slides were rinsed with Tris-buffered
saline with Tween 20, and treated with MACH-2 goat anti-mouse
alkaline phosphatase secondary antibody (Biocare Medical) for
30 min. Slides were rinsed with Tris-buffered saline with Tween 20,
and Vulcan Fast Red Chromagen Substrate (Biocare Medical) was
applied for 15 min. The slides were counterstained with Gill-II
Hematoxylin (Thermo Shandon, Pittsburgh, PA, USA) and cover-
slips were applied. Non-proximal tubules were also positively
stained red with alkaline phosphatase using a monoclonal mouse
antibody to kidney-specific cadherin (Zymed, San Francisco, CA,
USA), at a dilution of 1:50. Kidney-specific cadherin is known to be
expressed in the distal nephron.21 Other sections were stained with
MIB-1 antibody against Ki-67 antigen (DakoCytomation) using the
Dako Autostainer. Expression of the Ki-67 antigen has been reported
to be low in normal tubular epithelium22 but upregulated in injured
renal tubular epithelial cells.23
Quantitation of immunohistochemical staining
Kidney injury molecule-1-positive staining intensity in proximal
tubules of all biopsy cases from groups 1 to 3 was evaluated manually.
The staining intensity score of targeted and control epithelial cells
was graded from 0 to 3þ (0, no staining; 0.5±, weak fine granular
staining focally present along the luminal surface of non-atrophic
proximal tubules; 1þ , weak fine granular staining completely
surrounding the luminal surface of non-atrophic proximal tubules;
2þ , moderate granular staining completely surrounding the luminal
surface of non-atrophic proximal tubules and extending into inter-
cellular junctions; and 3þ , strong large granular staining completely
surrounding the luminal surface of non-atrophic proximal tubules
and extending into intercellular junctions).
Statistics
Results were expressed as mean±1 s.e.m. Data among groups were
compared using one-way analysis of variance (StatView program).
Correlation between KIM-1 staining scores and renal function indices
was assessed using simple regression analysis (StatView program).
A P-value less than 0.05 was considered significantly different.
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